breast cancer and semaglutide Weight loss drug shown to shrink in groundbreaking new study GLP-1 Medications and Breast Cancer:

This is likely due to Tirzepatides additional mechanism of action through GIP, enhancing its ability to decrease appetite and food intake

UT Southwestern and UTMB Awarded $500,000 TRC4 Grant to Study Non-Invasive Neurostimulation for Chronic Subdural Hematomas

Understanding how semaglutide affects hunger, satiety, and eating patterns can help patients set realistic expectations and optimize their treatment outcomes

In addition to weight loss, you can expect to feel better and calmer, be in more control and have more energy

Vander Heiden MG, Cantley LC, Thompson CB

In some cases, taking both may actually increase mild stomach upset